October 27-30, 2024

International Oncolytic Virus Conference

Stephen Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer presented “Engineering an oncolytic cytomegalovirus to recruit T cells into the tumor microenvironment and selectively transduce them with an anti-tumor CAR” at the IOVC meeting in Rotterdam, The Netherlands.  Kah-Whye Peng, Vyriad Chief Technical Officer, Luke Russell, Ph.D., Vyriad Vice-President of Business Development and Operations, and Shruthi Naik, Ph.D., Vyriad VP Comparative Oncology attended the International Oncolytic Virus Conference in Rotterdam, The Netherlands.